A ban on the sale, storage and use of Enerliv tablets was imposed in Ukraine. Such a decision was adopted by the State Service of Ukraine on Medicines and Drugs Control in early September, due to the lack of compliance of medical samples with Ukrainian legislation, RBC-UKRAINE reports.
The document refers to the prohibition on the sale, storage and use of the drug Enerliv of 74011 series. It is about a medicine in soft capsules of 300 MG packed in 10 capsules in a blister – 3 blisters in one package.
According to the order, all pharmacies must remove this drug from the sale or return it to the manufacturer. Otherwise, the offenders are subject to criminal liability.
As is known, the medicine Enerliv stabilizes and accelerates the restoration of cellular membranes of hepatocytes. It is used for liver diseases, toxicosis and radiation syndrome.
